Human leukocyte antigen class II alleles and rubella-specific humoral and cell-mediated immunity following measles-mumps-rubella-II vaccination

Journal of Infectious Diseases

Volumn 191, Issue 4, 2005, Pages 515-519

  Ovsyannikova, Inna G ^a   Jacobson, Robert M ^a   Vierkant, Robert A ^a   Jacobsen, Steven J ^a   Pankratz, V Shane ^a   Poland, Gregory A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DP ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; MEASLES MUMPS RUBELLA VACCINE; RUBELLA ANTIBODY;

ADOLESCENT; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; FEMALE; HUMAN; HUMORAL IMMUNITY; IMMUNOGENETICS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MALE; MASS IMMUNIZATION; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ALLELES; ANTIBODIES, VIRAL; CHILD; FEMALE; GENES, MHC CLASS II; HLA-DP ANTIGENS; HUMANS; IMMUNOGLOBULIN G; LYMPHOCYTE ACTIVATION; MALE; MEASLES-MUMPS-RUBELLA VACCINE; RUBELLA VIRUS; VACCINATION;

EID: 13444288135     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/427558     Document Type: Article

References (15)

1. Pettersson RF, Oker-Blom C, Kalkkinen N, et al. Molecular and antigenic characteristics and synthesis of rubella virus structural proteins. Rev Infect Dis 1985; 7:S140-9.
2. Frey T. Report of an international meeting on rubella vaccines and vaccination, 9 August 1993, Glasgow, United Kingdom. J Infect Dis 1994; 170:507-9.
3. Balfour HH Jr, Groth KE, Edelman CK, Amren DP, Best JM, Banatvala JE. Rubella viraemia and antibody responses after rubella vaccination and reimmunisation. Lancet 1981; 1:1078-80.
4. Mitchell LA, Tingle AJ, Décarie D, Shukin R. Identification of rubella virus T-cell epitopes recognized in anamnestic response to RA27/3 vaccine: associations with boost in neutralizing antibody titer. Vaccine 1999; 17:2356-65.
5. Chaye HH, Mauracher CA, Tingle AJ, Gillam S. Cellular and humoral immune responses to rubella virus structural proteins E1, E2, and C. J Clin Microbiol 1992; 30:2323-9.
6. Ou D, Mitchell LA, Décarie D, Tingle AJ, Nepom GT. Promiscuous T-cell recognition of a rubella capsid protein epitope restricted by DRB1*0403 and DRB1*0901 molecules sharing an HLA DR supertype. Hum Immunol 1998; 59:149-57.
7. Ou D, Mitchell LA, Ho M, et al. Analysis of overlapping T- and B-cell antigenic sites on rubella virus E1 envelope protein. Influence of HLA-DR4 polymorphism on T-cell clonal recognition. Hum Immunol 1994; 39:177-87.
8. Nepom GT, Domeier ME, Ou D, Kovats S, Mitchell LA, Tingle AJ. Recognition of contiguous allele-specific peptide elements in the rubella virus E1 envelope protein. Vaccine 1997; 15:648-52.
9. Pamer EG. Antigen presentation in the immune response to infectious diseases. Clin Infect Dis 1999; 28:714-6.
10. Poland GA, Ovsyannikova IG, Jacobson RM, et al. Identification of an association between HLA class II alleles and low antibody levels after measles immunization. Vaccine 2001; 20:430-8.
11. Ovsyannikova IG, Jacobson RM, Vierkant RA, Jacobsen SJ, Pankratz VS, Poland GA. The contribution of HLA class I antigens in immune status following two doses of rubella vaccination. Hum Immunol 2004; 65:1506-15.
12. Guo SW, Thompson EA. Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 1992; 48:361-72.
13. Castelli FA, Buhot C, Sanson A, et al. HLA-DP4, the most frequent HLA If molecule, defines a new supertype of peptide-binding specificity. J Immunol 2002; 169:6928-34.
14. al Daccak R, Wang FQ, Theophille D, Lethielleux P, Colombani J, Loiseau P. Gene polymorphism of HLA-DPB1 and DPA1 loci in caucasoid population: frequencies and DPB1-DPA1 associations. Hum Immunol 1991; 31:277-85.
15. Baselmans PJ, Pollabauer E, van Reijsen FC, et al. IgE production after antigen-specific and cognate activation of HLA-DPw4-restricted T-cell clones, by 78% of randomly selected B-cell donors. Hum Immunol 2000; 61:789-98.